Cancer treatment with vitamin C was first researched by Nobel-prize winner Linus Pauling in the 1970s. Massive oral doses, however, were not found to be effective according to Mayo Clinic. But researchers of the University of Puerto Rico are finding that intravenous (IV) massive doses just might be used as treatment (1-3).
The Bio-Communications Research Institute's RECNAC II project team led by Michael Gonzalez, Ph.D., has found that IV vitamin C is selectively toxic to cancerous tumor cells (1-3). The team hopes to someday establish that the treatment is an altertnative to highly toxic chemotherapy (4). Gonzalez hopes to have a book published soon about his experience (4).
Further research is needed to determine IV vitamin C-therapy's role in cancer treatment. It should not be considered an alternative cancer treatment.
References
1. Duconge J, Miranda-Massari JR, Gonzalez MJ, Jackson JA, Warnock W, Riordan NH. Pharmacokinetics of vitamin C: insights into the oral and intravenous administration of ascorbate. P R Health Sci J 2008;27:7-19.
2. Riordan HD, Casciari JJ, Gonzalez MJ et al. A pilot clinical study of continuous intravenous ascorbate in terminal cancer patients. P R Health Sci J 2005;24:269-76.
3. Riordan HD, Riordan NH, Jackson JA et al. Intravenous vitamin C as a chemotherapy agent: a report on clinical cases. P R Health Sci J 2004;23:115-8.
4. Personal communication with Michael Gonzalez.
No comments:
Post a Comment